Aveanna Healthcare (NASDAQ:AVAH) Trading Up 4.6% on Earnings Beat

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) shares were up 4.6% on Friday after the company announced better than expected quarterly earnings. The company traded as high as $8.04 and last traded at $7.7840. Approximately 388,583 shares changed hands during trading, a decline of 69% from the average daily volume of 1,261,986 shares. The stock had previously closed at $7.44.

The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.13 by $0.05. The firm had revenue of $647.92 million during the quarter, compared to the consensus estimate of $613.22 million. Aveanna Healthcare had a net margin of 9.25% and a return on equity of 481.69%. The business’s revenue was up 15.9% on a year-over-year basis.

Key Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Aveanna reported Q1 earnings of $0.18 per share, topping estimates of $0.13, while revenue came in at $647.9 million versus $613.2 million expected. The company also posted 15.9% year-over-year revenue growth and a sharp increase in net income, signaling solid operational momentum. Article Title
• Positive Sentiment: Management raised full-year 2026 guidance, lifting revenue expectations to $2.56 billion-$2.58 billion and adjusted EBITDA guidance to $328 million-$332 million. Higher forward targets suggest confidence in continued growth and margin improvement. Article Title
• Positive Sentiment: Stephens upgraded Aveanna Healthcare from “equal weight” to “overweight” and set an $11 price target, implying meaningful upside from recent trading levels. The upgrade adds another bullish catalyst for the stock. Article Title
• Neutral Sentiment: Multiple earnings call transcripts and recap articles mainly reiterate the same upbeat earnings and guidance story, reinforcing the positive narrative but adding little new information. Article Title

Wall Street Analysts Forecast Growth

A number of analysts have commented on AVAH shares. BMO Capital Markets reduced their price target on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a research report on Friday, March 20th. Truist Financial reduced their target price on shares of Aveanna Healthcare from $9.00 to $8.00 and set a “hold” rating for the company in a report on Monday, April 13th. Raymond James Financial upgraded shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 target price on the stock in a research note on Friday, March 20th. Barclays lowered their price target on shares of Aveanna Healthcare from $11.00 to $9.50 and set an “overweight” rating on the stock in a report on Wednesday, March 25th. Finally, Zacks Research lowered shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 3rd. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Aveanna Healthcare has a consensus rating of “Moderate Buy” and an average price target of $10.44.

Insider Activity at Aveanna Healthcare

In related news, CEO Jeff Shaner sold 173,225 shares of the business’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total value of $1,248,952.25. Following the transaction, the chief executive officer directly owned 2,650,892 shares of the company’s stock, valued at approximately $19,112,931.32. The trade was a 6.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Edwin C. Reisz sold 60,769 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $7.21, for a total value of $438,144.49. Following the completion of the transaction, the insider owned 1,447,057 shares of the company’s stock, valued at $10,433,280.97. The trade was a 4.03% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 738,957 shares of company stock worth $5,458,175 in the last three months. Corporate insiders own 5.30% of the company’s stock.

Hedge Funds Weigh In On Aveanna Healthcare

Several institutional investors have recently bought and sold shares of the stock. Entropy Technologies LP bought a new stake in Aveanna Healthcare in the 1st quarter valued at $156,000. State of Wyoming boosted its holdings in shares of Aveanna Healthcare by 15.7% during the 1st quarter. State of Wyoming now owns 73,838 shares of the company’s stock valued at $476,000 after purchasing an additional 9,995 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Aveanna Healthcare by 49.5% during the first quarter. Dimensional Fund Advisors LP now owns 1,334,374 shares of the company’s stock valued at $8,593,000 after purchasing an additional 441,707 shares in the last quarter. Precision Wealth Strategies LLC grew its position in shares of Aveanna Healthcare by 4.6% during the first quarter. Precision Wealth Strategies LLC now owns 137,706 shares of the company’s stock valued at $887,000 after purchasing an additional 6,115 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC increased its holdings in shares of Aveanna Healthcare by 11.4% in the first quarter. Allspring Global Investments Holdings LLC now owns 66,668 shares of the company’s stock worth $419,000 after purchasing an additional 6,823 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Aveanna Healthcare Stock Up 6.0%

The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 6.62. The stock has a market capitalization of $1.72 billion, a P/E ratio of 7.74 and a beta of 1.93. The company has a fifty day moving average price of $6.71 and a 200-day moving average price of $7.92.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.